未来一周收益：强生、NFLX、AAL、UAL、AXP、ABT、VZ、PG等

Despite a holiday-shortened week, a slew of major earnings reports from diverse industries is still set to grab investors' attention. Among the highlights, healthcare giant Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), telecom leader Verizon Communications (NYSE:VZ) and streaming giant Netflix (NASDAQ:NFLX) will provide insights into their performance and outlooks.

In the consumer goods space, The Procter & Gamble Company (NYSE:PG) will unveil its results, offering a snapshot of demand for household and personal care products. Texas Instruments (TXN) and Intuitive Surgical (ISRG) are set to report as well.

In the travel space, American Airlines Group (NASDAQ:AAL), Alaska Airlines (ALK) and United Airlines Holdings (NASDAQ:UAL) will reveal their earnings. Turning to finance, American Express (NYSE:AXP) will offer insights into consumer spending trends.

The industrial and materials sectors bring their own weight to the week, with reports from 3M (MMM), NextEra Energy (NEE), Union Pacific Corporation (UNP) and Halliburton (HAL), alongside commodities giants Freeport-McMoRan (FCX) and Alcoa Corporation (AA), offering insights into global demand trends for goods, transportation and resources.

Below is a rundown of major quarterly updates anticipated in the week of January 20 to January 24:

Monday, January 20

Markets will be closed in observance of Martin Luther King Day.

Tuesday, January 21

Netflix (NFLX)

Streaming giant Netflix (NFLX) is set to release its Q4 financial results on Tuesday, after the market closes.

The stock has surged over 75% over the past 12 months, garnering a Buy recommendation from Wall Street analysts, while Seeking Alpha's Quant Rating system currently assigns it a Hold.

SA contributor Noah's Arc Capital Management rates Netflix a Strong Buy, arguing that while the company has a high forward P/E ratio, its strong EPS growth justifies the premium. The analyst recognizes risks, such as the potential underperformance of new content, but emphasizes Netflix’s AI-driven strategies as key mitigators that will help ensure the company’s continued success.

On the contrary, Vladimir Dimitrov adopts a bearish stance on Netflix, acknowledging the optimism surrounding the company’s earnings growth in 2024. However, he predicts potential disappointment in FY 2025, citing concerns about margin pressures and slower-than-expected EPS growth. 

• Consensus EPS Estimates: $4.21
• Consensus Revenue Estimates: $10.11B
• Earnings Insight: Netflix has risen above EPS estimates in 6 of the past 8 quarters, while exceeding revenue expectations in 5 of those reports.

Also reporting: 3M Company (MMM), United Airlines Holdings (UAL), Seagate Technology Holdings (STX), D.R. Horton (DHI), Capital One Financial Corporation (COF), Prologis (PLD), United Microelectronics Corporation (UMC), KeyCorp (KEY), Fifth Third Bancorp (FITB), New Oriental Education & Technology Group (EDU), PACCAR (PCAR), Interactive Brokers Group (IBKR) and more.

Wednesday, January 22

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) is scheduled to announce its Q4 financial results before the market opens on Thursday. Analysts project a 5% Y/Y increase in sales, though EPS is expected to decline by over 10%, reflecting ongoing challenges.

The company recently submitted a New Drug Application to the FDA for its bladder cancer therapy candidate, TAR-200, highlighting progress in its oncology pipeline.

Wall Street analysts maintain a Buy consensus on the stock, while Seeking Alpha’s Quant Rating assigns it a Hold, citing growth and valuation concerns.

SA contributor The Alpha Sieve recommends holding the stock, emphasizing JNJ's attractive dividend yield, reasonable valuation, and favorable risk-reward profile despite some near-term hurdles.

• Consensus EPS Estimates: $2.04
• Consensus Revenue Estimates: $22.44B
• Earnings Insight: Johnson & Johnson (JNJ) has beaten EPS estimates in 8 straight quarters and exceeded revenue expectations in 6 of those reports.

Also reporting: The Procter & Gamble Company (PG), Kinder Morgan (KMI), Abbott Laboratories (ABT), Halliburton Company (HAL), Alcoa Corporation (AA), General Dynamics Corporation (GD), Crown Castle (CCI), Discover Financial Services (DFS), The Travelers Companies (TRV), Ally Financial (ALLY), United Rentals (URI), Steel Dynamics (STLD), SL Green Realty (SLG), Textron (TXT), GE Vernova (GEV), and more

Thursday, January 23

American Airlines Group (AAL)

American Airlines (AAL) is set to announce its Q4 results on Thursday, following an impressive performance and optimistic outlook from Delta Air Lines (DAL). Analysts project AAL’s profit to surge over 120% Y/Y, despite modest top-line growth, bolstered by robust holiday travel demand.

Seeking Alpha’s Quant Rating system assigns a Strong Buy to AAL, while Wall Street analysts echo a Buy recommendation.

Harrison Schwartz offers a bearish view, highlighting the significant EPS growth potential for AAL due to favorable industry dynamics, including the fallout from Spirit Airlines, which has eased cost pressures across the sector and strengthened AAL's margins. However, he points out risks such as high debt levels, the possibility of rising fuel prices, and economic uncertainty, which pose significant challenges. Schwartz warns that AAL’s valuation appears overly optimistic, with downside risks potentially outweighing the rewards, leading to a cautious long-term outlook.

• Consensus EPS Estimates:  $0.65
• Consensus Revenue Estimates: $13.40B
• Earnings Insight: AAL has topped EPS expectations in 7 of the past 8 quarters, while beating revenue estimates in 3 of those reports.

Also reporting: Freeport-McMoRan Inc. (FCX), Intuitive Surgical (ISRG), Union Pacific Corporation (UNP), CSX Corporation (CSX), Alaska Air Group (ALK), McCormick & Company, Incorporated (MKC), Old Republic International Corporation (ORI), TAL Education Group (TAL), Northern Trust Corporation (NTRS), and more.

Friday, January 24

American Express (AXP)

American Express (AXP), a financial services provider, is scheduled to release its Q4 results before the opening bell on Friday.

The company recently reported that its U.S. consumer credit card delinquency rate remained steady at 1.4% in December. However, the net write-off rate increased slightly to 2.1%, up from 2.0% in November, though it remains well below the 2.5% rate observed both a year ago and five years ago.

Both sell-side analysts and Seeking Alpha’s Quant Rating system maintain a Hold rating on American Express (AXP), which has soared 72% over the past 12 months, citing concerns over its valuation.

Seeking Alpha author Sandpiper Investment Research notes that, despite competitive pressures and potential economic risks, American Express’ resilient margins, strong balance sheet, and attractive valuation make it a compelling investment opportunity.

• Consensus EPS Estimates: $3.05
• Consensus Revenue Estimates: $17.18B
• Earnings Insight: The company has beaten EPS estimates in 5 of the past 8 quarters and revenue estimates in 3 of those reports.

Also reporting: Verizon Communications (VZ), NextEra Energy (NEE), American Express Company (AXP), Archer-Daniels-Midland Company (ADM), Telefonaktiebolaget LM Ericsson (publ) (ERIC), Teradyne, (TER), Xerox Holdings Corporation (XRX), Whirlpool Corporation (WHR), HCA Healthcare (HCA), NextEra Energy Partners, LP Common Units (NEP), and more.

More on related stocks:

• Johnson & Johnson: Q4 Earnings May Not Prompt Sustained Directional Moves
• Netflix: Sold After Solid Price Growth Without New Fuel Ahead Of Upcoming Report (Rating Downgrade)
• Netflix: 2024 Returns Will Weigh On 2025 Performance (Rating Downgrade)
• American Express to pay $109M to settle DOJ probe, finalization of Fed settlement pending
• American Express credit card metrics hold steady in December